`

Thursday, 20 July 2017

Pharma/BioPharma News

  • Cipla to explore marketing tie-up with Novartis

    Pharma/BioPharma |  News | 0 Comment | 14 Jul, 2017

    Cipla, India’s third largest drug maker, and Swiss giant Novartis are in early-stage discussions to jointly market asthma drug Xolair, just months after they ended a legal battle over...Read more

  • Takeda collaborates with Biological E

    Pharma/BioPharma |  News | 0 Comment | 27 Jun, 2017

    Japan’s Takeda and Biological E. Ltd. have agreed to collaborate on affordable combination vaccines. Takeda will transfer its measles and acellular pertussis vaccine bulk production ...Read more

  • Leo Pharma invests into Novopyxis

    Pharma/BioPharma |  News | 0 Comment | 22 Jun, 2017

    Leo Pharma announced an investment in the biotechnology company Novopyxis to support the development of an early-stage drug delivery device designed to increase the penetration of topical t...Read more

  • Glenmark starts a pact with APC Therapeutics

    Pharma/BioPharma |  News | 0 Comment | 21 Jun, 2017

    Domestic pharma major Glenmark Pharmaceuticals has entered into a licensing agreement with Boston-based APC Therapeutics Inc for development of a potential cancer treatment drug. Under the...Read more

  • AstraZeneca India receives marketing approval for Symbicort 320

    Pharma/BioPharma |  News | 0 Comment | 20 Jun, 2017

    AstraZeneca Pharma India Limited (AstraZeneca India), an international biopharmaceutical company has received marketing authorisation from the Drug Controller General of India (DCGI) for Sy...Read more

  • FDA approval to Zydus for migraine drug

    Pharma/BioPharma |  News | 0 Comment | 20 Jun, 2017

    Indian pharmaceutical major Zydus Cadila has managed to receive the final approval from the US health regulator Food and Drug Administration (USFDA) to market Eletriptan Hydrobromide tablet...Read more

  • Exclusive marketing rights to Pfizer in Europe

    Pharma/BioPharma |  News | 0 Comment | 16 Jun, 2017

    Pfizer and Basilea Pharmaceutica, an international biopharmaceutical company specializing in the research and development of anti-infective and oncological medicines, have entered into an a...Read more

  • USFDA nod for Aurobindo Pharma

    Pharma/BioPharma |  News | 0 Comment | 15 Jun, 2017

    Drug firm Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to make oral suspension used for controlling serum phosphorus in patients with chroni...Read more

  • Lupin’s opoid drug gets USFDA nod

    Pharma/BioPharma |  News | 0 Comment | 14 Jun, 2017

    Drug firm Lupin has received final approval from the United States Food and Drug Administration (USFDA) to market its Oxycodone Hydrochloride tablets USP, in the strengths of 5 mg, 10 mg, 1...Read more

  • Pain relief gel launched by Ozone Pharmaceuticals

    Pharma/BioPharma |  News | 0 Comment | 13 Jun, 2017

    Aiming to tap the huge market opportunity in the growing segment of topical analgesic gels, Indian pharma major Ozone Pharmaceuticals Ltd has launched DFO 4X Gel, an advanced topical analge...Read more

  • Generic Azilect tablets launched by Mylan

    Pharma/BioPharma |  News | 0 Comment | 05 Jun, 2017

    Mylan announced the U.S. launch of Rasagiline Tablets, 0.5 mg and 1 mg, a generic version of the reference listed drug, Teva's Azilect Tablets. Mylan received final approval from the U.S. F...Read more

  • Clinical trials for Bharat Biotech’s Chikungunya vaccine

    Pharma/BioPharma |  News | 0 Comment | 05 Jun, 2017

    Phase 1 human clinical trials of the indigenously developed Chikungunya (CHIKV) vaccine by Bharat Biotech is underway in India to evaluate the vaccine’s safety, tolerability and immun...Read more

  • Pfizer India to acquire AstraZeneca’s Neksium for Rs 750mn

    Pharma/BioPharma |  News | 0 Comment | 31 May, 2017

    Pfizer Limited (India) informed the stock exchange that it has entered into an agreement with AstraZeneca AB, Sweden, to acquire the brand “Neksium” in India for a value of INR ...Read more

  • Sun Pharma reports 9% growth in FY2017 at Rs. 30,264 crores

    Pharma/BioPharma |  News | 0 Comment | 30 May, 2017

    Sun Pharmaceutical Industries Ltd, India's top pharmaceutical company, reported a growth of 9% in sales / income from operations at Rs. 30,264 crores, over same period last year. The compa...Read more

  • Sun Pharma reports 8% drop in Q4 gross sales at Rs. 6,825 crores

    Pharma/BioPharma |  News | 0 Comment | 30 May, 2017

    Sun Pharmaceutical Industries Ltd, the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company reported de-growth of 8% in sales/ income Incom...Read more

  • Sun Pharma announces US FDA filing acceptance of BLA for Tildrakizumab

    Pharma/BioPharma |  News | 0 Comment | 30 May, 2017

    Sun Pharmaceutical Industries announced the U.S. Food and Drug Administration (FDA) acceptance of the Biologics License Application (BLA) for tildrakizumab. The FDA filing acceptance follow...Read more

  • Asthma drug by AstraZeneca fails

    Pharma/BioPharma |  News | 0 Comment | 10 May, 2017

    An experimental biotech drug for severe asthma from AstraZeneca failed to meet its goal of significantly reducing attacks in a late-stage study, dealing a blow to an approach that had alrea...Read more

  • Natco Pharma launches generic hepatitis C drug in India

    Pharma/BioPharma |  News | 0 Comment | 08 May, 2017

    Natco Pharma has launched a generic version of sofosbuvir 400 mg/velpatasvir 100 mg tablets, used for treatment of chronic hepatitis C, in India under the brand name Velpanat. The company'...Read more





Survey Box

Is digitalisation a global challenge for Indian pharma companies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls